What's New
Alignment of visit availability windows after Week 15. Ireland and South Korea removed as countries
App Description
Boehringer Ingelheim ePRO BI1403-0008 is intended to collect patient reported outcomes relating to a clinical trial (BI Trial 1403-0008 – Brightline-1). Patients must be given accounts by a participating site in order to log in to the app.
iPhone Screenshots
(click to enlarge)
iPad Screenshots
(click to enlarge)
App Changes
- October 17, 2022 Initial release
- September 15, 2023 New version 2.10.5 (18)
Other Apps From ERT, INC
